Initial Management of Functional Abdominal Pain in Adolescents
Begin with psychological interventions—specifically cognitive behavioral therapy or gut-directed hypnotherapy—as first-line treatment, combined with patient education about the brain-gut connection and low-dose tricyclic antidepressants if psychological therapy alone is insufficient. 1, 2
Establish the Foundation
Patient Education and Therapeutic Relationship
- Explain that the pain is real and originates from altered pain processing in the brain-gut axis, not from tissue damage or inflammation 3, 1
- Emphasize that central nervous system factors maintain and amplify pain through mechanisms like central sensitization, altered descending pain modulation, and changes in serotonergic and noradrenergic pathways 3
- Build an empathic, collaborative relationship as this directly impacts treatment success 1
Identify Risk Factors for Chronicity
- Screen for history of prior chronic pain, early-life adversity, trauma, discrimination experiences, or poverty 3
- Assess for catastrophizing, pre-existing anxiety, depression, or negative pain experiences 3
- Evaluate social environment including availability of positive support and pain-reinforcing factors like disability status or substance misuse history 3
First-Line Non-Pharmacological Interventions
Psychological Therapies (Highest Priority)
- Initiate cognitive behavioral therapy (CBT) early as it produces the strongest evidence for long-term symptom improvement in adolescents 1, 2
- Consider gut-directed hypnotherapy which shows superiority to standard care with long-term benefits, particularly effective for functional abdominal pain 2, 3
- Use guided imagery with audio recordings for home-based treatment, which demonstrates significantly greater decrease in pain days compared to standard care 2
- Apply biofeedback for patients who respond well to technology-based self-regulation approaches 3, 2
- Select hypnotherapy specifically for patients with visceral hypersensitivity or somatic symptoms, unless severe PTSD is present 3
Dietary Modifications
- Involve a dietitian early to prevent overly restrictive diets 1
- Trial individualized dietary adjustments but use high-fiber diets cautiously as they may worsen symptoms 1
- Consider low FODMAP diet under dietitian supervision for patients reporting food-triggered symptoms 4
- Recommend small, frequent meals and avoidance of high-fat foods 4
Physical Activity
- Prescribe regular exercise to reduce pain perception and offset movement avoidance behaviors 1
Pharmacological Management
First-Line Medications
- Start low-dose tricyclic antidepressants (TCAs) such as amitriptyline for baseline therapy, which can be managed by primary care or gastroenterology 3, 1
- Consider smooth muscle relaxants (mebeverine, pinaverium bromide) which improve abdominal pain by 18% over placebo 1
Second-Line Medications (If First-Line Fails)
- Add serotonin-norepinephrine reuptake inhibitors (SNRIs) like duloxetine for patients with limited response to TCAs 3, 1
- For severe refractory cases, consider combination neuromodulator therapy (e.g., duloxetine plus gabapentin) 1
Critical Pitfalls to Avoid
- Never prescribe opioids as they cause narcotic bowel syndrome, worsen gastrointestinal symptoms, and increase risk of dependence and hyperalgesia 3, 1
- Avoid antimotility drugs like loperamide in adolescents due to serious side effect risks 2
- Do not recommend dietary restrictions without dietitian guidance 1
- Avoid focusing solely on medications without addressing psychological factors 1
- Do not perform unnecessary surgical interventions 1
When to Escalate Care
Refer to Multidisciplinary Pain Team When:
- Symptoms remain severe or disabling despite first-line psychological therapy and TCAs 3, 1
- Significant psychiatric comorbidities require psychologist or psychiatrist involvement 3
- Patient shows poor insight into thought-feeling-behavior-pain relationships (may need alternative to CBT) 3
- Combination neuromodulator therapy is being considered 1
Red Flags Requiring Urgent Investigation:
- Weight loss, nocturnal symptoms, or rectal bleeding suggesting organic disease 4
- Age-related concerns or family history of GI malignancy or inflammatory bowel disease 4
This algorithmic approach prioritizes evidence-based psychological interventions while providing pharmacological support when needed, avoiding the common pitfall of over-reliance on medications alone or the dangerous use of opioids in this population.